Predictive Factors on the Results of Epidural Adhesiolysis in Patient With Chronic Spinal Pain
Sponsor
Diskapi Teaching and Research Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05235308
Collaborator
(none)
50
1
1.8
27.7
Study Details
Study Description
Brief Summary
The primary aim of this exploratory study was to determine the demographic, clinical, and technical factors associated with treatment outcome, to create a better select treatment candidates.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
50 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Predictive Factors on the Results of Percutaneous Epidural Adhesiolysis in Patient With Chronic Spinal Pain
Actual Study Start Date
:
Jan 1, 2022
Actual Primary Completion Date
:
Feb 1, 2022
Anticipated Study Completion Date
:
Feb 25, 2022
Outcome Measures
Primary Outcome Measures
- pain intensity [baseline to 12 months post-procedure]
The visual analog scale is a numerical scale from 0 to 10; with 0 representing no pain and 10 representing the worst pain imaginable.
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- patients in whom percutaneous epidural lysis of adhesions was performed
Exclusion Criteria:
-
nonadhesiolytic procedure
-
lack of follow-up
-
incomplete outcome data
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Diskapi Yildirim Beyazit Training and Research Hospital | Ankara | Turkey | 06110 |
Sponsors and Collaborators
- Diskapi Teaching and Research Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Selin Guven Kose,
Principal investigator,
Diskapi Teaching and Research Hospital
ClinicalTrials.gov Identifier:
NCT05235308
Other Study ID Numbers:
- 127/22
First Posted:
Feb 11, 2022
Last Update Posted:
Mar 2, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: